City of Huntington, West Virginia v. AmerisourceBergen Drug Corporation

CourtDistrict Court, S.D. West Virginia
DecidedMarch 11, 2021
Docket3:17-cv-01362
StatusUnknown

This text of City of Huntington, West Virginia v. AmerisourceBergen Drug Corporation (City of Huntington, West Virginia v. AmerisourceBergen Drug Corporation) is published on Counsel Stack Legal Research, covering District Court, S.D. West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
City of Huntington, West Virginia v. AmerisourceBergen Drug Corporation, (S.D.W. Va. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA THE CITY OF HUNTINGTON, Plaintiff, v. CIVIL ACTION NO. 3:17-01362 AMERISOURCEBERGEN DRUG CORPORATION, et al., Defendants. ________________________________ CABELL COUNTY COMMISSION, Plaintiff, v. CIVIL ACTION NO. 3:17-01665 AMERISOURCEBERGEN DRUG CORPORATION, et al., Defendants. ________________________________ MEMORANDUM OPINION AND ORDER Pending before the court are defendants’ motions: (1) to exclude the testimony of Dr. Rahul Gupta; and (2) to exclude undisclosed expert testimony. See ECF Nos. 1051 and 1055. Those motions are fully briefed and they were argued before the court on January 6, 2021. I. Dr. Rahul Gupta served as the West Virginia Department of Health and Human Resources Health Commissioner from 2015 to 2018. From 2009 to 2014, Dr. Gupta was the Executive Director of the Kanawha-Charleston Health Department. On August 3, 2020, plaintiffs disclosed Dr. Gupta as a non- retained expert. On September 11, 2020, Dr. Gupta was deposed. Almost two months later, on October 30, 2020, plaintiffs provided supplemental disclosures required by Federal Rule of Evidence 26(a)(2)(C). Plaintiffs have never provided an expert report pursuant to Rule 26(a)(2)(B). Defendants move to exclude Dr. Gupta from providing expert testimony because plaintiffs did not provide an expert report. Plaintiffs maintain they were not required to provide an expert report because Dr. Gupta was not a retained expert in this case. Rule 26(a)(2)(B) provides that an expert witness must be identified and provide a written report if he or she “is one retained or specially employed to provide expert testimony in the case or one whose duties as the party's employee regularly involve giving expert testimony.” Fed. R. Civ. P. 26(a)(2)(B). In 2010, Rule 26 was amended to add subsection (C), which states: (C) Witnesses Who Do Not Provide a Written Report. Unless otherwise stipulated or ordered by the court, if the witness is not required to provide a written report, this disclosure must state: (i) the subject matter on which the witness is expected to present evidence under Federal Rule of Evidence 702, 703, or 705; and (ii) a summary of the facts and opinions to which the witness is expected to testify. Fed. R. Civ. P. 26(a)(2)(C). According to the Advisory Committee Notes, this amendment was enacted to “resolve[ ] a tension that 2 has sometimes prompted courts to require reports under Rule 26(a)(2)(B) even from witnesses exempted from the report requirement.” Fed. R. Civ. P. 26 advisory committee's notes. “Frequent examples include physicians or other health care professionals and employees of a party who do not regularly provide expert testimony.” Id. According to one court, the Advisory Committee Notes suggest that “Rule 26(a)(2)(C) is meant to apply only to so-called hybrid witnesses, i.e., fact witnesses who can also provide expert testimony under Federal Rules of Evidence 702, 703, or 705.” Call v. City of Riverside, No. 3:13- cv-133, 2014 WL 2048194, *3 (S.D. Ohio May 19, 2014). Of the difference between retained and non-retained experts, one court summarized: A retained or specialty expert is “an expert who without prior knowledge of the facts giving rise to litigation is recruited to provide expert testimony.” Downey v. Bob’s Disc. Furniture Holdings, 633 F.3d 1, 6 (1st Cir. 2011). A non-retained expert is one whose testimony arises from his or her involvement in events giving rise to the litigation. Compass Bank v. Eager Road Associates, LLC, No. 4:12CV1059JCH, 2013 WL 5786634, *4 (E.D. Mo. Oct. 28, 2013). The Downey court goes on to note that in “[i]nterpreting the words ‘retained or specially employed’ in a common-sense manner, consistent with their plain meaning, we conclude that as long as an expert was not retained or specially employed in connection with the litigation, and his opinion about causation is premised on 3 personal knowledge and observations made in the course of treatment, no report is required under the terms of Rule 26(a)(2)(B).” 633 F.3d at 7. At his deposition on September 11, 2020, Dr. Gupta testified that he had been retained by the Fitzsimmons Law Firm as an expert consultant in the West Virginia Mass Litigation Panel opioid litigation. Attorneys from the Fitzsimmons Law Group, Mark Colantonio and Bob Fitzsimmons appeared as counsel for Dr. Gupta at his deposition. Previously, on July 14, 2020, Mr. Colantonio had entered an appearance “as counsel for Plaintiffs” in these cases. See ECF No. 729. When defendants passed Dr. Gupta as a witness for questioning by plaintiffs’ counsel, Mr. Colantonio asked a number of questions of Dr. Gupta. Counsel for McKesson and Cardinal Health objected to Mr. Colantonio’s questioning of Dr. Gupta because Dr. Gupta was “not a party, so he’s not entitled to be run through a direct examination by his personal counsel.” Deposition of Dr. Rahul Gupta, September 11, 2020, at 117 (found at Appendix to Defendants’ Motion). Whereupon, Mr. Colantonio took the position that he was questioning Dr. Gupta in his

capacity as Dr. Gupta’s attorney as well as in his role as counsel for plaintiffs. See id. at 117-18. Later in the deposition, after he had asked a number of questions of Dr. Gupta, Mr. Colantonio backtracked and stated that he was 4 appearing at the deposition solely as counsel for Dr. Gupta and not on behalf of plaintiffs. See id. at 185-87. A few things are clear. First, while not expressly prohibited, Mr. Colantonio’s questioning of Dr. Gupta was highly unusual and not permitted by the Federal Rules of Civil Procedure. Federal Rule of Civil Procedure 30(c)(1) mandates that “[t]he examination and cross-examination of a deponent proceed as they would at trial under the Federal Rules of Evidence . . . .” And nonparty attorneys do not ask witnesses questions at trial. Second, contrary to plaintiffs’ assertions, defendants did object to Mr. Colantonio’s questions. And finally, notwithstanding the foregoing, Dr. Gupta is not a retained expert in these cases. Therefore, by the plain language of the Rule, Dr. Gupta is not a retained expert required to provide an expert report. To hold otherwise, requires rewriting Rule 26(a)(2)(B) to provide that an expert witness must provide a written report if he is “retained or specially employed to provide expert testimony in the case [or in another case that is very similar and/or overlaps with the case or where the attorney for the expert witness is

also counsel in this case].” (alterations in italics). This the court declines to do. Therefore, the motion seeking to exclude Dr. Gupta because he did not provide an expert report is DENIED.

5 II. That does not end the court’s inquiry with respect to Dr. Gupta or the other seven witnesses plaintiffs have designated as non-retained experts: Christina Mullins; Dr. Michael Kilkenny; Dr. Kevin Yingling; Dr. Todd Davies; Dr. David Chaffin; Dr. Lynn O’Connell; and Dr. Stephen Petrany.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
City of Huntington, West Virginia v. AmerisourceBergen Drug Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/city-of-huntington-west-virginia-v-amerisourcebergen-drug-corporation-wvsd-2021.